Literature DB >> 29158237

Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.

Lei Huang1, Lina Jansen1,2, Yesilda Balavarca3, Esther Molina-Montes4, Masoud Babaei1, Lydia van der Geest5, Valery Lemmens5, Liesbet Van Eycken6, Harlinde De Schutter6, Tom B Johannesen7, Claus W Fristrup8, Michael B Mortensen9, Maja Primic-Žakelj10, Vesna Zadnik10, Nikolaus Becker11, Thilo Hackert12, Margit Mägi13, Tiziana Cassetti14, Romano Sassatelli14, Robert Grützmann15, Susanne Merkel15, Ana F Gonçalves16, Maria J Bento16, Péter Hegyi17, Gábor Lakatos18, Andrea Szentesi17, Michel Moreau19, Tony van de Velde20, Annegien Broeks20, Milena Sant21, Pamela Minicozzi21, Vincenzo Mazzaferro22, Francisco X Real23,24, Alfredo Carrato25, Xavier Molero26,27, Marc G Besselink28, Núria Malats4, Markus W Büchler12, Petra Schrotz-King3, Hermann Brenner1,2,3.   

Abstract

OBJECTIVE: Resection can potentially cure resectable pancreatic cancer (PaC) and significantly prolong survival in some patients. This large-scale international study aimed to investigate variations in resection for PaC in Europe and USA and determinants for its utilisation.
DESIGN: Data from six European population-based cancer registries and the US Surveillance, Epidemiology, and End Results Program database during 2003-2016 were analysed. Age-standardised resection rates for overall and stage I-II PaCs were computed. Associations between resection and demographic and clinical parameters were assessed using multivariable logistic regression models.
RESULTS: A total of 153 698 records were analysed. In population-based registries in 2012-2014, resection rates ranged from 13.2% (Estonia) to 21.2% (Slovenia) overall and from 34.8% (Norway) to 68.7% (Denmark) for stage I-II tumours, with great international variations. During 2003-2014, resection rates only increased in USA, the Netherlands and Denmark. Resection was significantly less frequently performed with more advanced tumour stage (ORs for stage III and IV versus stage I-II tumours: 0.05-0.18 and 0.01-0.06 across countries) and increasing age (ORs for patients 70-79 and ≥80 versus those <60 years: 0.37-0.63 and 0.03-0.16 across countries). Patients with advanced-stage tumours (stage III-IV: 63.8%-81.2%) and at older ages (≥70 years: 52.6%-59.5%) receiving less frequently resection comprised the majority of diagnosed cases. Patient performance status, tumour location and size were also associated with resection application.
CONCLUSION: Rates of PaC resection remain low in Europe and USA with great international variations. Further studies are warranted to explore reasons for these variations. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  TNM stage; age; pancreatic cancer; population-based; surgical resection; variation

Mesh:

Year:  2017        PMID: 29158237     DOI: 10.1136/gutjnl-2017-314828

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Pancreatectomy with Vascular Resection After Neoadjuvant FOLFIRINOX: Who Survives More Than a Year After Surgery?

Authors:  Laurent Sulpice; Olivier Turrini; Jonathan Garnier; Fabien Robin; Jacques Ewald; Ugo Marchese; Damien Bergeat; Karim Boudjema; Jean-Robert Delpero
Journal:  Ann Surg Oncol       Date:  2021-01-18       Impact factor: 5.344

2.  Nomogram predicting the cancer-specific survival of early-onset colorectal cancer patients with synchronous liver metastasis: a population-based study.

Authors:  Xueliang Ding; Xiaodong Yang; Dafu Wu; Yaguang Huang; Yanwen Dai; Jiajing Li; Weilong Chang; Mozhen Chi; Shaobo Tian
Journal:  Int J Colorectal Dis       Date:  2022-05-07       Impact factor: 2.571

Review 3.  [Oligometastasis in pancreatic cancer : Current state of knowledge and spectrum of local therapy].

Authors:  F Gebauer; A I Damanakis; C Bruns
Journal:  Chirurg       Date:  2018-07       Impact factor: 0.955

4.  Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study.

Authors:  Xueliang Ding; Shaobo Tian; Jia Hu; Guobin Wang; Xiangnan Yu; Daan Fu; Ye Yuan; Lin Wang; Zheng Wang
Journal:  Int J Colorectal Dis       Date:  2021-06-01       Impact factor: 2.571

5.  Underutilization of Surgery in Periampullary Cancer Treatment.

Authors:  Christoph W Michalski; Bing Liu; Max Heckler; Susanne Roth; Huihui Sun; Ulrike Heger; Markus W Büchler; Thilo Hackert
Journal:  J Gastrointest Surg       Date:  2018-08-07       Impact factor: 3.452

6.  Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Amanda L Blackford; Marcia Irene Canto; Alison P Klein; Ralph H Hruban; Michael Goggins
Journal:  J Natl Cancer Inst       Date:  2020-11-01       Impact factor: 13.506

7.  Score for predicting overall survival in pancreatic adenocarcinoma patients with positive lymph nodes after surgery: a novel nomogram-based risk assessment.

Authors:  Liang Jin; Yiping Zou; Shiye Ruan; Hongwei Han; Yuanpeng Zhang; Zhihong Chen; Haosheng Jin; Ning Shi
Journal:  Gland Surg       Date:  2021-02

8.  Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma.

Authors:  Miquel Porta; José Pumarega; André F S Amaral; Jeanine M Genkinger; Judit Camargo; Lorelei Mucci; Juan Alguacil; Magda Gasull; Xuehong Zhang; Eva Morales; Mar Iglesias; Shuji Ogino; Lawrence S Engel
Journal:  Environ Res       Date:  2020-06-11       Impact factor: 6.498

9.  Largely varying patterns and trends of primary cancer-directed resection for gastric carcinoma with synchronous distant metastasis in Europe and the US: a population-based study calling for further standardization of care.

Authors:  Lei Huang; Lina Jansen; Rob H A Verhoeven; Jelle P Ruurda; Liesbet Van Eycken; Harlinde De Schutter; Jan Johansson; Mats Lindblad; Tom B Johannesen; Vesna Zadnik; Tina Žagar; Margit Mägi; Sjoerd M Lagarde; Esther Bastiaannet; Cornelis J H van de Velde; Petra Schrotz-King; Hermann Brenner
Journal:  Ther Adv Med Oncol       Date:  2021-06-28       Impact factor: 8.168

Review 10.  Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer-A Comprehensive Review.

Authors:  Greta Brezgyte; Vinay Shah; Daria Jach; Tatjana Crnogorac-Jurcevic
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.